Recommendations and current practices for the reconstitution and storage of botulinum toxin type A

Journal of the American Academy of Dermatology

Volumn 67, Issue 3, 2012, Pages 373-378

  Liu, Austin ^a   Carruthers, Alastair ^b   Cohen, Joel L ^c   Coleman III, William P ^d   Dover, Jeffrey S ^e   Hanke, C William ^f   Moy, Ronald L ^g   Ozog, David M ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c AboutSkin Dermatology and DermSurgery PC   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e SKINCARE PHYSICIANS   (United States)

^f Laser and Skin Surgery Center of Indiana   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botox; Botox reconstitution; Botox storage; botulinum toxin; botulinum toxin consensus recommendations; botulinum toxin reconstitution; botulinum toxin storage

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; DRUG CONTAMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG STERILITY; DRUG STORAGE; HUMAN; INFECTION; INFECTION CONTROL; INTERNET; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BOTULINUM TOXINS, TYPE A; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DRUG CONTAMINATION; DRUG STORAGE; GUIDELINES AS TOPIC; HEALTH CARE SURVEYS; HUMANS; INJECTIONS; PHYSICIAN'S PRACTICE PATTERNS; SODIUM CHLORIDE; UNITED STATES;

EID: 84865017456     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.10.008     Document Type: Article

References (17)

1. M. Alam, J.S. Dover, and K.A. Arndt Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double blind, randomized controlled trial Arch Dermatol 138 2002 510 514 (Pubitemid 34290028)
2. D.M. Kwiat, T.A. Bersani, and A. Bersani Increased patient comfort utilizing botulinum toxin type A reconstituted with preserved versus nonpreserved saline Ophthal Plast Reconstr Surg 20 2004 186 189 (Pubitemid 38679531)
3. J.D. Siegel, E. Rhinehart, M. Jackson, L. Chiarello Health Care Infection Control Practices Advisory Committee 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings Am J Infect Control 35 Suppl 2007 S65 S164
4. Joint Commission. Accreditation program: hospital infection prevention and control. Available from: URL: http://www.premierinc.com/quality-safety/ tools-services/safety/topics/influenza/downloads/HAP-IC-09-incl-influenza.pdf. Accessed March 1, 2011.
5. WPS Medicare. Coding and billing: botulinum toxin type A and type B. Available from: URL: http://wpsmedicare.com/j5macpartb/policy/active/local/- files/l28555-inj018-cbg.pdf. Accessed March 1, 2011.
6. J. Carruthers, S. Fagien, S.L. Matarasso Botox Consensus Group Consensus recommendations on the use of botulinum toxin type A in facial aesthetics [review] Plast Reconstr Surg 114 Suppl 2004 1 22S
7. M.A. Jabor, R. Kaushik, P. Shayani, A. Ruiz-Razura, B.K. Smith, and K.W. Morimoto Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit Plast Reconstr Surg 111 2003 2419 2431
8. M.G. Gartlan, and H.T. Hoffman Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage Otolaryngol Head Neck Surg 108 1993 135 140 (Pubitemid 23086689)
9. M. Lizarralde, S.H. Gutiérrez, and A. Venegas Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines Dermatol Surg 33 2007 1328 1333 (Pubitemid 47624083)
10. R.R. Sloop, B.A. Cole, and R.O. Escutin Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use Neurology 48 1997 249 253 (Pubitemid 27039549)
11. J.I. Hui, and W.W. Lee Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids Ophthal Plast Reconstr Surg 23 2007 433 438 (Pubitemid 350146480)
12. D. Hexsel, M.S. Rutowitsch, L.C. de Castro, D.Z. do Prado, and M.M. Lima Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection Dermatol Surg 35 2009 933 940
13. G.C. Yang, R.J. Chiu, and G.S. Gillman Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox Arch Facial Plast Surg 10 2008 273 279
14. D.M. Hexsel, A.T. De Almeida, M. Rutowitsch, I.A. De Castro, V.L. Silveira, and D.O. Gobatto Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application Dermatol Surg 29 2003 523 529 (Pubitemid 36583152)
15. A.A. Parsa, K.D. Lye, and F.D. Parsa Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use Aesthetic Plast Surg 31 2007 188 193
16. J. Menon, and A. Murray Microbial growth in vials of botulinum toxin following use in clinic Eye (Lond) 21 2007 995 997 (Pubitemid 47062086)
17. M. Alam, S.S. Yoo, D.A. Wrone, L.E. White, and J.Y. Kim Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation J Am Acad Dermatol 55 2006 272 275 (Pubitemid 44038009)